Chronic bronchitis (CB) is an indicator of an increased risk of developing COPD, but its symptoms are often underestimated. Demographic and socio-economic conditions might influence its prevalence, reporting and impact.
Introduction
Chronic obstructive pulmonary disease (COPD) is a growing and leading cause of mortality, handicap and healthcare costs worldwide 1 but remains largely under-diagnosed. 2, 3 Questionnaire-based screening has been advocated, 2 but external validation of standardized questionnaires provided conflicting results. 4 Although chronic bronchitis (CB) is not considered anymore as an early stage of COPD, 5 its presence definitely remains a marker of increased risk of developing the disease. 6 In addition, studies suggest that, although CB is markedly under-diagnosed in the general population, it has a noticeable impact on health status, working ability and healthcare resource consumption. 7, 8 Socio-economic conditions could influence the risk of CB (e.g., through differences in smoking habits and exposure to other airborne pollutants including occupational hazards) while age, gender, socio-economic and cultural background, working activities and, more generally, life style may influence the impact and reporting of respiratory symptoms and access to healthcare resources.
The present analysis was performed to assess the prevalence, impact and reporting of CB, and how they are influenced by demographic and socio-economic conditions in the French general population.
Methods

Survey design, study population and data collection
The data analyzed here came from the fifth French health interview survey conducted by the National Institute of Statistics and Economical Studies in 2002e2003. Details on sampling and interviews are provided in the electronic supplementary material. The study population comprised adults aged 45 years or older identified in a representative sample of 25,021 households randomly selected from population databases. Data were collected through face-to-face interviews and self-administered questionnaires, 9 and addressed socio-demographic characteristics, self-rated health status, known respiratory diseases, declared incapacity, morbidity and loss of working time as well as respiratory symptoms and tobacco use (see details in the electronic supplementary material). Chronic bronchitis was defined as the association of chronic cough and sputum on most days for at least 3 months per year during at least 2 consecutive years. Dyspnea was categorized in 2 classes: modified Medical Research Council grade 1 or 2.
Statistical analysis
Backward stepwise logistic regression models were used to assess how demographic and socio-economic variables influence the prevalence and reporting of CB and its impact on self-rated health status and physical incapacity. Analyses were performed using STATA software [Stata Corp., College Station, TX, USA].
Results
Study population, prevalence and risk factors of chronic bronchitis
Complete data were available in 9050 subjects (64.8% of all adults aged 45 years or more in the source population sample). Comparisons between responders and nonresponders and characteristics of the study population are provided in the electronic supplementary material. The prevalence of chronic cough or expectoration was 9.6%, that of chronic bronchitis was 3.5% (95% CI, 3.1e4.5), and 3.4% of subjects reported a diagnosis of chronic respiratory disease compatible with COPD.
Factors associated with a higher prevalence of chronic bronchitis are presented in Table 1 . Independent associations were found with male gender, age, smoking, lower income and occupational category, the highest prevalence being observed in manual and self-employed workers.
Health status, medical resource utilization and loss of working time Self-rated health status was poorer and physical incapacities were more frequent among persons with chronic bronchitis (Table 2) . When analyses were restricted to people with dyspnea grade 0 or 1, chronic bronchitis remained associated with poorer health status (51% versus 30%, adjusted OR 2.4 [1.5e3.8]) and a higher proportion of activity limitation (25% versus 14%, aOR 1.8 [1.1e3.1]). Chronic bronchitis was associated with an increase in the proportion of patients visiting a general practitioner (in men), a specialist (in women) or a hospital in the previous year ( Table 2 ). The proportion of subjects reporting loss of work because of health problems was higher among those with chronic bronchitis (men 24% versus 18% aOR 1.4 [0.9e2.1]; women 35% versus 15% aOR 3.3 [2.0e5.5]), even when the analyses were restricted to people with no or mild dyspnea (data not shown).
Chronic bronchitis and self-reported morbidity
There was a wide mismatch between known diagnoses of chronic respiratory disease and reporting of CB symptoms. Among people with symptoms of CB, 32% declared a known diagnosis of chronic respiratory disease (28% among men and 40% among women), while among those with a known diagnosis of chronic respiratory disease, 33% reported symptoms of CB. In subjects with symptoms of CB, a known diagnosis of chronic respiratory disease was reported less frequently by men (aOR 0.4 [95% CI, 0.2e0.9]) and subjects with higher annual income (aOR 0.3 [0.1e0.7]). Subjects with symptoms of chronic bronchitis declared cardiovascular diseases more frequently (aOR: 1,9 [1,4e2,7] ).
Discussion
The prevalence of CB was 3.5% in this sample of the French general population aged 45 years. A previous diagnosis of chronic respiratory disease was reported by only one third of subjects with symptoms of CB. Symptoms of CB were associated with functional limitation, an impairment of self-rated health status and daily activities and work loss. Symptoms of chronic bronchitis were associated with smoking status, male gender, increasing age and lower socio-economic conditions while under-diagnosis was more pronounced in men and subjects with higher socioeconomic status.
Strengths and limitations of the study
One strength of the present study is that several markers of socio-economic conditions were systematically assessed including school grade, income and socio-professional category. The response rate is comparable to that of similar surveys 8 and the sampling and adjustments methods ensured that the sample was as representative of the French population as possible. The prevalence rates might be considered as underestimates since, as in all communitybased epidemiological surveys, people with poorer health status are less likely to participate. 10 To avoid overestimating the frequency of CB, patients reporting only chronic cough or expectoration were not included in prevalence estimates.
Prevalence and under-diagnosis of chronic bronchitis
The prevalence of CB reported here is remarkably close to previous data in the French adult population (4.1% for CB), 8 with a similar association with male gender, increasing age and smoking and a similar proportion of CB patients with no previous diagnosis of chronic respiratory disease (about 2/3).
Only a few recent surveys assessed the prevalence of CB in the general population. In the first ECRHS survey performed in 1991e1993 in adults aged 20e44 years, the median prevalence of CB was 2.6%, with wide variations between countries that could not be explained only by differences in the proportion of smokers, 11 suggesting a contribution of other factors such as socio-economic conditions.
Factors associated with the prevalence of chronic bronchitis and a known diagnosis of chronic respiratory disease compatible with COPD Only few studies assessed the relationship between CB or COPD and socio-economic status. 12 Here the risk of CB appears inversely related to socio-economic status, as reflected by a lower income and/or socio-professional category. In the follow-up phase of the ECRHS study (CB prevalence: 6.9%), 13 risk factors of chronic phlegm production were smoking, rhinitis, poor education and low social class, occupational exposures in men and traffic intensity and home outdoor NO 2 levels in women. In the present study, the relationship between CB and socio-economic conditions could relate to differential exposures to environmental or occupational air pollution, low birth weight, respiratory infections during infancy or environmental tobacco, which were not specifically assessed. The lower prevalence of CB could relate to the more stringent definition, the sampling method or a lower proportion of active smokers.
Men reported a known diagnosis of chronic respiratory disease less frequently than women, despite a higher prevalence of symptoms of chronic bronchitis. Several studies showed that women seek medical advice more frequently than men, suggesting the need to consider gender-related differences in health behavior and tolerance of symptoms in prevention strategies.
14,15 Among subjects with CB, patients with higher income reported less diagnosis of chronic respiratory disease, which may relate to less physically demanding activities.
Impact of chronic bronchitis and modifying factors
CB is associated with a worse perceived health status, functional limitation, decrease of daily activities, loss of working time and a higher medical resource consumption. Interestingly, an impact of CB was shown even in patients who reported no or very mild dyspnea. Such results further expand that of previous studies 3, 7, 8 and emphasize that CB symptoms should be considered as indicators of an increased risk of significant impairment in health status and use of healthcare resources.
In conclusion, chronic bronchitis is frequent in the French general population and has a significant impact on health status, functional limitation, healthcare resource utilization and work loss, even in the absence of significant dyspnea. Chronic bronchitis is more frequent in men and low socio-economic categories, but men and individuals with higher income tend to seek medical advice less frequently when they experiment symptoms of CB. Thus, subjects with CB should be specific targets of prevention and detection strategies, which should account for demographic and socio-economic influences.
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